Top

Autologous Stem Cell Transplantation International Crohn's Disease Trial: a multicentre, prospective, randomised phase II study conducted by the European Crohn's and Colitis Organisation (ECCO), sponsored by the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation

Type d'étude:

Clinical Trials Phase I-III

Numéro de l'étude:

2005-003337-40

Type de traitement:

Maladies:

Auto immune disorders

Titre court:

ASTIC

Objectif principal:

To evaluate the potential clinical benefit of hematopietic stem cell mobilisation by high dose immunoablation and autologous stem cell transplantation versus hematopoietic stem cell mobilisation only followed by best clinical practice in patients with Crohn's disease

Principaux critères d'inclusion:

18-50 years old

Pays:

Royaume Uni

France

République tchèque

Allemagne

Italie

Espagne

Suisse

Canada

Investigateur principal:

Christopher J Hawkey

Coordinateur EBMT de l'étude:

Janette Zarev

http://clinicaltrials.gov/ct2/show/NCT00297193